At MSK, we diagnose and treat many pulmonary diseases associated with patients who are immunocompromised by cancer, bone marrow transplantation, or HIV. My clinical expertise is in the area of lung injury in this patient population, which can arise from a multiplicity of etiologies including infections (routine, opportunistic, and esoteric), the treatment of underlying disease, and many other causes of lung injury that may or may not be related to the patient’s immunocompromised state. In this setting I have become adept in the differential diagnosis of abnormal radiographic findings and in the treatment of interstitial lung disorders and other lung diseases, both in the immunocompromised and immunocompetent host.
My research interests include the evaluation, diagnosis, and treatment of pulmonary diseases in the immunocompromised host. I have published 49 peer-reviewed papers on the topic and have written more than 70 chapters, editorials, and review articles. In 1984, we published one of the first and largest series on the usefulness of bronchoalveolar lavage (BAL) in the diagnosis of pulmonary disease in the immunocompromised host. BAL is now used all over the world as the primary diagnostic procedure in this patient population. We have also published articles on pulmonary disease in HIV patients and unique types of lung injuries related and unrelated to cancer therapy.
Another passion of mine has been to counsel children and young adults on the dangers of smoking. I have developed many educational tools used by medical professionals and teachers to help children and young adults make the decision not to smoke. I have also spoken to children and young adults in grammar schools, colleges, and medical schools; appeared on TV; and spoken on the radio about this topic. After 9/11, I took part in the smoking cessation program at the New York City Fire Department to help first responders quit smoking. I have testified before Congress and lobbied to limit the accessibility of nicotine products to children. These activities are among my proudest accomplishments.
- Clinical Expertise: Pulmonary Diseases; Pulmonary Disease in the Immunocompromised Patient; Pulmonary Complications of Cancer and Therapy; Pulmonary Complications Associated with HIV Infection; Lung Cancer; Bronchoscopy
- Languages Spoken: English
- Education: MD, Albert Einstein College of Medicine
- Residencies: Harlem Hospital Center; The New York Hospital/Cornell Medical Center
- Fellowships: Bronx Municipal Hospital Center
- Board Certifications: Internal Medicine; Pulmonary Disease
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more